Nuveen Fund Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
– Sell
-2,423
Closed -$545K – 269
2017
Q4
$545K Sell
2,423
-1,303
-35% -$278K 0.16% 164
2017
Q3
$707K Sell
3,726
-257
-6% -$48.9K 0.14% 183
2017
Q2
$749K Sell
3,983
-484
-11% -$87K 0.12% 208
2017
Q1
$739K Sell
4,467
-1,680
-27% -$267K 0.1% 238
2016
Q4
$884K Buy
6,147
+2,701
+78% +$362K 0.13% 198
2016
Q3
$432K Sell
3,446
-167
-5% -$21.6K 0.06% 316
2016
Q2
$475K Buy
+3,613
New +$494K 0.07% 279

Other funds holding ELV

Nuveen Fund Advisors's ELV Position: Q1 2018 in Review

Nuveen Fund Advisors sold out of Elevance Health (ELV) in Q1 2018, closing a stake of 2,423 shares — an estimated $545K sold.

Nuveen Fund Advisors first reported a position in ELV in Q2 2016 and held it in 7 quarters. The position peaked at $884K in Q4 2016. 924 funds tracked by Wall St. Rank hold ELV as of Q1 2018.

  • Nuveen Fund Advisors reported no remaining Elevance Health position as of Q1 2018 after selling out during the quarter.
  • Nuveen Fund Advisors sold 2,423 Elevance Health shares in Q1 2018, an estimated $545K.
  • Nuveen Fund Advisors first reported a position in Elevance Health in Q2 2016 and held it in 7 quarters.
  • Nuveen Fund Advisors's Elevance Health position peaked at $884K in Q4 2016.
  • 924 funds tracked by Wall St. Rank held Elevance Health as of Q1 2018.

Based on Nuveen Fund Advisors's 13F filing for Q1 2018, filed 14 May 2018.